Quidel Corporation (QDEL)
QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
Johnson & Johnson - Johnson & Johnson reports Q4 and Full-Year 2025 results
Johnson & Johnson reports Q4 and Full-Year 2025 results
Natera - Natera Publishes Clinical Validation ofLatitude™ Tissue-Free MRD Test in Colorectal Cancer
IO Biotech, Inc. - IO Biotech Announces Exploration of Strategic Alternatives